Zobrazeno 1 - 10
of 4 604
pro vyhledávání: '"Her-2"'
Autor:
Boyan Huang, Guanyin Huang, Jingru Lian, Mengxing Diao, Xinliang Zhong, Wenlian Yao, Dongmei Ran, Xin Hong, Jingwen Chen, Liping Wang
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Apocrine carcinoma associated with Paget’s disease is a rare malignancy that typically manifests in elderly individuals, predominantly affecting the geriatric population. It commonly arises in regions rich in apocrine glands and
Externí odkaz:
https://doaj.org/article/c3bcde8eae494360af7566dac7a06a6c
Autor:
Takayuki Kobayashi, Meiko Nishimura, Mari Hosonaga, Rika Kizawa, Saori Kawai, Yosuke Aoyama, Yukinori Ozaki, Ippei Fukada, Fumikata Hara, Toshimi Takano, Takayuki Ueno
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Absolute lymphocyte count (ALC) is a predictive and prognostic factor for various tumor types, including breast cancer. Palbociclib is a CDK4/6 inhibitor widely used for the treatment of metastatic estrogen receptor (ER)-positive,
Externí odkaz:
https://doaj.org/article/1e6f7c53792d4145b42f0e111048dcb5
Autor:
Dai Okemoto, Toshifumi Yamaguchi, Mariko Yamaguchi, Toru Kadono, Hiroki Yukami, Elham Fakhrejahani, Hiroki Nishikawa
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1001-1007 (2024)
Introduction: In recent years, trastuzumab and pertuzumab have been used in treatment protocols for patients with HER2-positive colorectal cancer. Although severe thrombocytopenia is an uncommon side effect of anti-HER2 antibody therapy, we present t
Externí odkaz:
https://doaj.org/article/1642784669d742c396cf1d2633a51794
Publikováno v:
Caspian Journal of Internal Medicine, Vol 15, Iss 4, Pp 606-614 (2024)
Background: Bladder cancer is the 5th most prevalent cancer among Iranian men. Finding prognostic markers to predict behavior of this cancer can help us to choose the best treatment for patients from the first place. We aimed to evaluate the correlat
Externí odkaz:
https://doaj.org/article/86df410f6e6a414aa147ec377997d1b2
Autor:
Shivangi Agarwal, Monalisa Parija, Sanoj Naik, Pratima Kumari, Sandip K. Mishra, Amit K. Adhya, Sushil K. Kashaw, Anshuman Dixit
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-19 (2024)
Abstract Breast invasive carcinoma (BRCA) is the most malignant and leading cause of death in women. Global efforts are ongoing for improvement in early detection, prevention, and treatment. In this milieu, a comprehensive analysis of RNA-sequencing
Externí odkaz:
https://doaj.org/article/0459bb96a5244d0ea1121b11843a71ca
Autor:
Mehmet Uzun, Elif Atag, Eda Caliskan Yildirim, Murat Keser, Huseyin Salih Semiz, Olcun Umit Unal
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Biomarkers such as hormone receptors (HR) and human epidermal growth factor receptor2 (HER2) may change after neoadjuvant chemotherapy (NAC) in breast cancer patients. The aim of this study was to investigate the rates of receptor change aft
Externí odkaz:
https://doaj.org/article/d7ddd3ddd7f245d98d03a79420554f9d
Autor:
Menekse Turna, Hale Başak Çağlar
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
This case series presents four instances of late neurotoxicity observed in HER2-positive breast cancer patients with brain metastases following treatment with stereotactic radiosurgery (SRS) and subsequent trastuzumab emtansine (T-DM1) therapy. Despi
Externí odkaz:
https://doaj.org/article/88487f336c2f4f099f7ade8d8c962785
Autor:
Vladimir I. Evdokimov, Anatoly A. Bloshchinenko, Alexander E. Abolmasov, Alexey A. Vilensky, Michail S. Laskov
Publikováno v:
Современная онкология, Vol 25, Iss 3, Pp 336-341 (2023)
Aim. To evaluate the effectiveness of trastuzumab deruxtecan in real-world practice in the Russian Federation. Materials and methods. We performed a retrospective analysis of clinical case series related to the use of trastuzumab deruxtecan (N=15)
Externí odkaz:
https://doaj.org/article/02e2f51c5f464211a7ce2b5365c62c79